BRANDACE LOWE: Open Payments
NPI 1003474271 · HOISINGTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 8 payments from 6 companies in 2025. Trend: 2023 $213 · 2024 $153 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Novo Nordisk Inc | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: REXULTI, SAPIEN 3 Ultra RESILIA, Ozempic, LEQVIO, FARXIGA, BEXSERO.
Industry payments across KS — which companies pay providers there.
